Yumizen C1200 CRP
C-Reactive Protein, Antigen, Antiserum, And Control. 510(k) K192028, from Horiba Abx SAS (Montpellier Cedex 4, FR). Product code DCK, class 2.
As of Nov 18, 2026, K192028 is an FDA 510(k) held by Horiba Abx SAS, substantially equivalent on Jun 25, 2020 after 335 days, with no recalls tied to it in FDA's recall database.
- Review time: 335 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFYumizen C1200 CRP reagent is intended for the quantitative in vitro diagnostic determination of the C-reactive protein in human serum and lithium heparin plasma based on an immunoturbidimetric assay. Measurement of C-reactive protein aids in evaluation of the amount of injury to body tissues and for evaluation of infections, tissue injury and inflammatory disorders.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- QuikRead go CRP, QuikRead go CRP Verification Set, QuikRead go CRP Control Set, and QuikRead go InstrumentK142993 · Orion Diagnostica, OY · Mar 10, 2016
- Olympus Crp Latex Reagent, OSR6199; Olympus Crp Latex Calibrator Normal Set, ODC0026; Olympus Crp Latex Calibrator HighK051564 · Olympus America, Inc. · Aug 22, 2005
Other DCK clearances
The newest 510(k)s for the same product code; see every DCK device- K-ASSAY CRP (Ver.2)K242170 · Kamiya Biomedical Company, LLC · Apr 18, 2025
- Procise CRP, ProciseDx Analyzer, ProciseDx Calibration CartridgeK201256 · Procise Diagnostics · Nov 4, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 26, 2019
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5270
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files